📣 Introducing Tracenable Pro: Unlock Unlimited Data Exports & Disclosures Access.

Huadong Medicine Co Ltd

Common Name
Huadong Medicine
Country
China (Mainland)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
18,265
Ticker
000963
Exchange
SHENZHEN STOCK EXCHANGE
Description
Huadong Medicine Co., Ltd. is an influential player in the pharmaceutical manufacturing sector, primarily focused on research, development, production, and distribution of a wide range of medicinal pr...

Huadong Medicine's GHG Emissions Data Preview

In 2024, Huadong Medicine completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, Huadong Medicine has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2024202320222021 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
b
0000000
Total Scope 2
Unspecified Calculation Method
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
b
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
b
0000000
Download Data
Access this data via API
$curl "https://tracenable.com/api/v1/ghg-emissions/absolute?ticker=000963&reporting_period=2024"

Verified Sources Behind Huadong Medicine’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Huadong Medicine’s data sources below and access millions more through our Disclosure Search.

a. Huadong Medicine's ESG Report 2024
a. Huadong Medicine's ESG Report 2024
b. Huadong Medicine's ESG Report 2023
b. Huadong Medicine's ESG Report 2023

Insights into Huadong Medicine's Operational Emissions

In 2024, the total operational greenhouse gas (GHG) emissions ofHuadong Medicine amounted to186,953.8metric tons of CO2 equivalent.This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a

Compared to 2023, the total operational greenhouse gas (GHG) emissions of Huadong Medicineincreased by 22.91%, suggesting that the company faced challenges in reducing its emissions from its core operations.a

Huadong Medicine's Scope 1 Emissions Over Time

20222023202404 k8 k12 k16 ktCO2e+26%+9%
  • Total Scope 1
  • Year-over-Year Change

What are Huadong Medicine's Scope 1 emissions?

In 2024, the total Scope 1 emissions of Huadong Medicine were 15,594.79 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).a

Has Huadong Medicine reduced its Scope 1 emissions over time?

Since 2022, Huadong Medicine's Scope 1 emissions have increased by 37.94%, reflecting a rising long-term trend in Scope 1 emissions over time.ab

Compared to the previous year(2023), Huadong Medicine's Scope 1 emissions increased by 9.14%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.a

What are Huadong Medicine's Scope 2 emissions?

In 2024, Huadong Medicine reported Scope 2 greenhouse gas (GHG) emissions of 171,359.01 tCOâ‚‚e without specifying the calculation method.a

Has Huadong Medicine reduced its Scope 2 emissions over time?

Since 2022, Huadong Medicine's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method)have increased by 76.13%, reflecting a rising long-term trend in Scope 2 emissions over time.ab

Compared to the previous year(2023), Huadong Medicine's Scope 2 emissions(Unspecified Calculation Method) rose by 24.34% in 2024, suggesting that the company faced challenges in reducing emissions from purchased electricity and energya

What methodology does Huadong Medicine use for Scope 2 reporting?

In 2024, Huadong Medicine reported its Scope 2 emissions using an unspecified methodology.a

Huadong Medicine's Scope 2 Emissions Over Time

202220232024045 k90 k135 k180 ktCO2e
  • Total Scope 2 (Unspecified Calculation Method)

Insights into Huadong Medicine’s GHG Emissions Intensity Compared to Industry Peers

In 2024, Huadong Medicine reported Scope 1 greenhouse gas (GHG) emissions of 15,594.79 tCOâ‚‚e and total revenues of USD 5,742 millions. This translates into an emissions intensity of 2.72 tCOâ‚‚e per millions USD.a

Huadong Medicine's Scope 1 Emissions Intensity Compared to Peers

102005,000100,0002,000,000Scope 1 Emissions (tCO2e)5502002,00010,000Revenues (Millions of USD)ZCCPADSDCHZZZhejiang NhuYear: 2024Scope 1: 765,023 tCO2eRevenue: $M 2,961Scope 1 Intensity: 258.37 tCO2e/$MCanSino BiologicsYear: 2023Scope 1: 3,541 tCO2eRevenue: $M 49Scope 1 Intensity: 72.91 tCO2e/$MSimcere Pharmaceutical GroupYear: 2023Scope 1: 4,997 tCO2eRevenue: $M 1,017Scope 1 Intensity: 4.91 tCO2e/$MWalvax BiotechnologyYear: 2024Scope 1: 7,643 tCO2eRevenue: $M 387Scope 1 Intensity: 19.77 tCO2e/$MCCCR Double-CraneYear: 2024Scope 1: 58,155 tCO2eRevenue: $M 1,536Scope 1 Intensity: 37.86 tCO2e/$MHumanwell Healthcare GroupYear: 2024Scope 1: 19,500 tCO2eRevenue: $M 3,485Scope 1 Intensity: 5.60 tCO2e/$MLuye Pharma GroupYear: 2023Scope 1: 10,755 tCO2eRevenue: $M 945Scope 1 Intensity: 11.38 tCO2e/$MLivzon Pharmaceutical GroupYear: 2024Scope 1: 194,441 tCO2eRevenue: $M 1,619Scope 1 Intensity: 120.13 tCO2e/$MCCChangchun High-TechYear: 2023Scope 1: 61,590 tCO2eRevenue: $M 2,050Scope 1 Intensity: 30.05 tCO2e/$MHansoh Pharmaceutical GroupYear: 2024Scope 1: 13,163 tCO2eRevenue: $M 1,830Scope 1 Intensity: 7.19 tCO2e/$MJoincareYear: 2024Scope 1: 197,854 tCO2eRevenue: $M 2,140Scope 1 Intensity: 92.45 tCO2e/$MPPPorton Pharma SolutionsYear: 2024Scope 1: 18,865 tCO2eRevenue: $M 413Scope 1 Intensity: 45.71 tCO2e/$MBioKangtaiYear: 2023Scope 1: 15,952 tCO2eRevenue: $M 489Scope 1 Intensity: 32.60 tCO2e/$MZhejiang Jiuzhou PharmaceuticalYear: 2023Scope 1: 48,815 tCO2eRevenue: $M 777Scope 1 Intensity: 62.81 tCO2e/$MYunnan Baiyao GroupYear: 2024Scope 1: 15,079 tCO2eRevenue: $M 5,485Scope 1 Intensity: 2.75 tCO2e/$MConsun Pharmaceutical GroupYear: 2023Scope 1: 54,210 tCO2eRevenue: $M 398Scope 1 Intensity: 136.27 tCO2e/$MAAApeloa PharmaceuticalYear: 2024Scope 1: 10,400 tCO2eRevenue: $M 1,647Scope 1 Intensity: 6.31 tCO2e/$MDDDong-E-E-JiaoYear: 2023Scope 1: 15,659 tCO2eRevenue: $M 663Scope 1 Intensity: 23.60 tCO2e/$MFosun PharmaYear: 2024Scope 1: 184,016 tCO2eRevenue: $M 5,627Scope 1 Intensity: 32.70 tCO2e/$MSSSihuan PharmaceuticalYear: 2023Scope 1: 45,602 tCO2eRevenue: $M 286Scope 1 Intensity: 159.27 tCO2e/$MTasly Pharmaceutical GroupYear: 2024Scope 1: 37,370 tCO2eRevenue: $M 1,164Scope 1 Intensity: 32.09 tCO2e/$MHua MedicineYear: 2023Scope 1: 19 tCO2eRevenue: $M 12Scope 1 Intensity: 1.63 tCO2e/$MHepalinkYear: 2024Scope 1: 18,284 tCO2eRevenue: $M 724Scope 1 Intensity: 25.27 tCO2e/$MDDDa Ren TangYear: 2023Scope 1: 5,902 tCO2eRevenue: $M 1,157Scope 1 Intensity: 5.10 tCO2e/$MCCChina Resources SanjiuYear: 2024Scope 1: 55,312 tCO2eRevenue: $M 3,784Scope 1 Intensity: 14.62 tCO2e/$MHHHuadong MedicineYear: 2024Scope 1: 15,595 tCO2eRevenue: $M 5,742Scope 1 Intensity: 2.72 tCO2e/$M

How does Huadong Medicine's GHG emissions intensity compare to its peers?

In 2024, Huadong Medicine reported a Scope 1 emissions intensity of 2.72 tCOâ‚‚e per millions USD. Compared to the peer group median of 30.05, this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors.a

Where does Huadong Medicine rank on GHG emissions intensity within its industry?

In 2024, Huadong Medicine ranked 2 out of 25 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCOâ‚‚e per millions USD).a

This places Huadong Medicine among the top performers, with one of the lowest emissions intensities relative to peers.a

Want Full Access to Huadong Medicine's GHG Emissions Dataset?
Sign Up